GTC Biotherapeutics (fka GTCB)

[Beerzoids]

=== Dr. Cox’s open-market purchase yesterday probably means that there will be no material positive news (either clinical data or a partnership) during the rest of December. It also suggests that the terms of a partnership deal—even a deal contingent on the phase-3 clinical data—are not yet finalized. ===

The 10,000 share purchase, by Cox, represents about a 4% increase in his holdings. If news does come out during December, would a small purchase, like that, be considered a violation of insider trading by the SEC?